Literature DB >> 11926074

"Cade's disease" and beyond: misdiagnosis, antidepressant use, and a proposed definition for bipolar spectrum disorder.

S Nassir Ghaemi1, James Y Ko, Frederick K Goodwin.   

Abstract

The diagnosis and treatment of bipolar disorder (BD) has been inconsistent and frequently misunderstood in recent years. To identify the causes of this problem and suggest possible solutions, we undertook a critical review of studies concerning the nosology of BD and the effects of antidepressant agents. Both the underdiagnosis of BD and its frequent misdiagnosis as unipolar major depressive disorder (MDD) appear to be problems in patients with BD. Underdiagnosis results from clinicians' inadequate understanding of manic symptoms, from patients' impaired insight into mania, and especially from failure to involve family members or third parties in the diagnostic process. Some, but by no means all, of the underdiagnosis problem may also result from lack of agreement about the breadth of the bipolar spectrum, beyond classic type I manic-depressive illness (what Ketter has termed "Cade's Disease"). To alleviate confusion about the less classic varieties of bipolar illness, we propose a heuristic definition, "bipolar spectrum disorder." This diagnosis would give greater weight to family history and antidepressant-induced manic symptoms and would apply to non-type I or II bipolar illness, in which depressive symptom, course, and treatment response characteristics are more typical of bipolar than unipolar illness. The role of antidepressants is also controversial. Our review of the evidence leads us to conclude that there should be less emphasis on using antidepressants to treat persons with this illness.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11926074     DOI: 10.1177/070674370204700202

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN: 0706-7437            Impact factor:   4.356


  53 in total

1.  Why Psychiatrists are Reluctant to Diagnose: Borderline Personality Disorder.

Authors:  Joel Paris
Journal:  Psychiatry (Edgmont)       Date:  2007-01

2.  Association between bipolar spectrum features and treatment outcomes in outpatients with major depressive disorder.

Authors:  Roy H Perlis; Rudolf Uher; Michael Ostacher; Joseph F Goldberg; Madhukar H Trivedi; A John Rush; Maurizio Fava
Journal:  Arch Gen Psychiatry       Date:  2010-12-06

3.  Impaired sustained attention and executive dysfunction: bipolar disorder versus depression-specific markers of affective disorders.

Authors:  Fadi T Maalouf; Crystal Klein; Luke Clark; Barbara J Sahakian; Edmund J Labarbara; Amelia Versace; Stefanie Hassel; Jorge R C Almeida; Mary L Phillips
Journal:  Neuropsychologia       Date:  2010-02-20       Impact factor: 3.139

4.  Mood-Stabilizing Effect of Twice-Weekly Administration of Fluoxetine in a Bipolar II Disorder Patient.

Authors:  Amir Shabani
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2007

Review 5.  Medication effects in neuroimaging studies of bipolar disorder.

Authors:  Mary L Phillips; Michael J Travis; Andrea Fagiolini; David J Kupfer
Journal:  Am J Psychiatry       Date:  2008-02-01       Impact factor: 18.112

Review 6.  The increasing frequency of mania and bipolar disorder: causes and potential negative impacts.

Authors:  Sean H Yutzy; Chad R Woofter; Christopher C Abbott; Imad M Melhem; Brooke S Parish
Journal:  J Nerv Ment Dis       Date:  2012-05       Impact factor: 2.254

Review 7.  Prospective: Is bipolar disorder being overdiagnosed?

Authors:  Tammas Kelly
Journal:  Int J Methods Psychiatr Res       Date:  2018-06-14       Impact factor: 4.035

Review 8.  Problems in the boundaries of bipolar disorders.

Authors:  Joel Paris
Journal:  Curr Psychiatry Rep       Date:  2014-08       Impact factor: 5.285

9.  Genome-wide scan for genes involved in bipolar affective disorder in 70 European families ascertained through a bipolar type I early-onset proband: supportive evidence for linkage at 3p14.

Authors:  B Etain; F Mathieu; M Rietschel; W Maier; M Albus; P McKeon; S Roche; C Kealey; D Blackwood; W Muir; F Bellivier; C Henry; C Dina; S Gallina; H Gurling; A Malafosse; M Preisig; F Ferrero; S Cichon; J Schumacher; S Ohlraun; M Borrmann-Hassenbach; P Propping; R Abou Jamra; T G Schulze; A Marusic; Z M Dernovsek; B Giros; T Bourgeron; A Lemainque; D Bacq; C Betard; C Charon; M M Nöthen; M Lathrop; M Leboyer
Journal:  Mol Psychiatry       Date:  2006-03-14       Impact factor: 15.992

10.  Polarity of the first episode and time to diagnosis of bipolar I disorder.

Authors:  Boseok Cha; Jeong Hyun Kim; Tae Hyon Ha; Jae Seung Chang; Kyooseob Ha
Journal:  Psychiatry Investig       Date:  2009-06-30       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.